XBiotech, Inc. (XBIT)
1.91
-0.06
(-3.05%)
USD |
NASDAQ |
Oct 23, 16:00
1.91
0.00 (0.00%)
After-Hours: 20:00
XBiotech EPS Diluted (Quarterly) : -0.2207 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2207 |
| March 31, 2026 | -0.1806 |
| December 31, 2025 | -0.8821 |
| September 30, 2025 | -0.1971 |
| June 30, 2025 | -0.0576 |
| March 31, 2025 | -0.357 |
| December 31, 2024 | -0.3447 |
| September 30, 2024 | -0.1646 |
| June 30, 2024 | -0.427 |
| March 31, 2024 | -0.3285 |
| December 31, 2023 | -0.1523 |
| September 30, 2023 | -0.242 |
| June 30, 2023 | -0.2872 |
| March 31, 2023 | -0.1254 |
| December 31, 2022 | -0.1052 |
| September 30, 2022 | -0.4158 |
| June 30, 2022 | -0.3825 |
| March 31, 2022 | -0.1796 |
| December 31, 2021 | -0.2125 |
| September 30, 2021 | -0.1075 |
| June 30, 2021 | -0.1707 |
| March 31, 2021 | -0.0873 |
| December 31, 2020 | -0.0627 |
| September 30, 2020 | -0.087 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.2372 |
| March 31, 2020 | -0.0004 |
| December 31, 2019 | 14.82 |
| September 30, 2019 | -0.1499 |
| June 30, 2019 | -0.156 |
| March 31, 2019 | -0.163 |
| December 31, 2018 | -0.1702 |
| September 30, 2018 | -0.141 |
| June 30, 2018 | -0.1649 |
| March 31, 2018 | -0.1148 |
| December 31, 2017 | -0.20 |
| September 30, 2017 | -0.18 |
| June 30, 2017 | -0.26 |
| March 31, 2017 | -0.32 |
| December 31, 2016 | -0.5026 |
| September 30, 2016 | -0.38 |
| June 30, 2016 | -0.42 |
| March 31, 2016 | -0.32 |
| December 31, 2015 | -0.3683 |
| September 30, 2015 | -0.33 |
| June 30, 2015 | -0.22 |
| March 31, 2015 | -0.29 |
| December 31, 2014 | -0.1857 |
| December 31, 2013 | -0.0784 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.728M |
| Total Expenses (Quarterly) | 6.728M |
| Enterprise Value | -49.47M |
| Earnings Yield | -77.51% |
| Normalized Earnings Yield | -77.51 |